The pharmaceutical industry is experiencing a major shift toward outsourcing, particularly in solid oral dosage forms such as tablets and capsules. Rising demand for tablet manufacturing services, increasing reliance on capsule manufacturing outsourcing, and the expansion of pharmaceutical outsourcing market strategies are reshaping global drug production models. At the center of this transformation is the growing Oral Solid Dosage Contract Manufacturing Market, which continues to expand as pharmaceutical companies seek cost efficiency, scalability, and advanced manufacturing capabilities.

The global oral solid dosage contract manufacturing market was valued at USD 35.98 billion in 2023. It is projected to grow from USD 37.82 billion in 2024 to USD 57.02 billion by 2032, registering a CAGR of 5.3% during the forecast period (2024–2032).

Tablet Manufacturing Services: Backbone of Oral Solid Dosage Production

Tablet manufacturing services form the largest segment of oral solid dosage production due to the widespread use of tablets as a preferred drug delivery format. Tablets are widely favored because they are stable, cost-effective, easy to transport, and offer accurate dosing.

Modern tablet manufacturing includes multiple advanced processes such as:

• Powder blending and granulation
• Compression using high-speed tablet presses
• Film coating for stability and controlled release
• Quality testing for hardness, dissolution, and uniformity

Contract manufacturing organizations (CMOs) provide end-to-end tablet production services ranging from early formulation development to large-scale commercial manufacturing. These services allow pharmaceutical companies to focus on research and marketing while outsourcing complex production activities.

Technological advancements such as high-shear granulation, continuous manufacturing, and automated quality control systems are further enhancing efficiency and precision in tablet production. This has significantly strengthened the position of tablet manufacturing within the Oral Solid Dosage Contract Manufacturing Market.

Capsule Manufacturing Outsourcing: Enhancing Flexibility and Patient Compliance

The trend of capsule manufacturing outsourcing is gaining momentum as pharmaceutical companies increasingly seek flexible, patient-friendly drug delivery formats. Capsules offer several advantages, including easier swallowing, faster drug release, and the ability to encapsulate both solid and liquid formulations.

Capsule manufacturing involves processes such as:

• Gelatin or HPMC capsule shell production
• Filling with powders, pellets, or granules
• Encapsulation of modified-release formulations
• Quality assurance and stability testing

Outsourcing capsule production to specialized CDMOs enables pharmaceutical companies to scale production efficiently while maintaining regulatory compliance and product quality. Capsules are also widely used for modified-release and pediatric formulations, making them a key growth segment in the Oral Solid Dosage Contract Manufacturing Market.

The rising demand for personalized medicine and patient-centric dosage forms is further boosting capsule manufacturing outsourcing across global pharmaceutical companies.

Pharmaceutical Outsourcing Market: Strategic Shift Toward CDMO Models

The broader pharmaceutical outsourcing market is evolving rapidly as companies move away from in-house manufacturing toward contract development and manufacturing organizations (CDMOs). This shift is driven by increasing cost pressures, regulatory complexities, and the need for specialized manufacturing expertise.

Key benefits of pharmaceutical outsourcing include:

• Reduced capital investment in manufacturing facilities
• Faster time-to-market for new drugs
• Access to advanced manufacturing technologies
• Improved scalability and production flexibility
• Compliance with stringent global regulatory standards

Outsourcing also allows pharmaceutical companies to focus on core competencies such as drug discovery, clinical trials, and commercialization. The growing complexity of drug formulations, especially for small molecule drugs, has made outsourcing an essential strategy for both large and mid-sized pharmaceutical firms.

This structural shift is a major driver behind the expansion of the Oral Solid Dosage Contract Manufacturing Market globally.

Oral Solid Dosage Contract Manufacturing Market: Growth Drivers and Industry Expansion

The global Oral Solid Dosage Contract Manufacturing Market is witnessing strong growth due to several interconnected factors:

• Rising demand for generic drugs worldwide
• Increasing outsourcing by pharmaceutical companies
• Growth in chronic disease prevalence requiring long-term medication
• Expansion of tablet and capsule-based drug pipelines
• Cost efficiency and operational flexibility offered by CDMOs
• Technological advancements in continuous manufacturing systems

Oral solid dosage forms, particularly tablets and capsules, account for a significant share of pharmaceutical production due to their stability, patient compliance, and ease of manufacturing.

North America leads the market due to strong pharmaceutical infrastructure and high outsourcing adoption, while Asia-Pacific is emerging as a key growth region driven by low-cost manufacturing capabilities and expanding pharmaceutical production hubs.

Discover the Complete Report Here:

https://www.polarismarketresearch.com/industry-analysis/oral-solid-dosage-contract-manufacturing-market

Some of the major players operating in the global market include:

• AbbVie Contract Manufacturing
• Aenova Group
• Alkem Laboratories
• Catalent, Inc.
• Dr. Reddy's Laboratories
• Evonik Industries AG
• Famar Health Care Services
• Granules India Limited
• Jubilant Life Sciences
• Lonza Group
• Patheon (now part of Thermo Fisher Scientific)
• Pfizer CentreOne
• Piramal Pharma Solutions
• Recipharm AB
• Vetter Pharma International GmbH

Future Outlook

The future of Oral Solid Dosage Contract Manufacturing, capsule manufacturing outsourcing, and the broader pharmaceutical outsourcing market is expected to be shaped by digital transformation and advanced manufacturing technologies. CDMOs are increasingly adopting automation, predictive analytics, and real-time quality monitoring systems to enhance production efficiency and regulatory compliance.

More Trending Latest Reports By Polaris Market Research:

Ankylosing Spondylitis Market

Fertility Supplements Market

aorto-iliac occlusive disease (iliac disease) treatment market

Drug Testing Market

Real World Evidence Solutions Market

North America AI in Medical Imaging Market

Blood-Based Biomarker For Parkinson’s Disease Market

U.S. Remote Patient Monitoring System Market